BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9839807)

  • 1. Cloning and characterization of the CDKN2A and p19ARF genes from Monodelphis domestica.
    Sherburn TE; Gale JM; Ley RD
    DNA Cell Biol; 1998 Nov; 17(11):975-81. PubMed ID: 9839807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the CDKN2A and ARF genes in UV-induced melanocytic hyperplasias and melanomas of an opossum (Monodelphis domestica).
    Chan J; Robinson ES; Atencio J; Wang Z; Kazianis S; Coletta LD; Nairn RS; McCarrey JR
    Mol Carcinog; 2001 May; 31(1):16-26. PubMed ID: 11398194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-ras oncogene activation in invasive UVR-induced corneal sarcomas of the opossum Monodelphis domestica.
    Kusewitt DF; Gale JM; Sherburn TE; Tafoya GB; Ley RD
    DNA Cell Biol; 1997 Oct; 16(10):1217-22. PubMed ID: 9364932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 tumor suppressor gene of the marsupial Monodelphis domestica: cloning of exons 4-11 and mutations in exons 5-8 in ultraviolet radiation-induced corneal sarcomas.
    Kusewitt DF; Sherburn TE; Miska KB; Tafoya GB; Gale JM; Miller RD
    Carcinogenesis; 1999 Jun; 20(6):963-8. PubMed ID: 10357774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D
    Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4a or p19ARF.
    Sarkar-Agrawal P; Vergilis I; Sharpless NE; DePinho RA; Rünger TM
    J Natl Cancer Inst; 2004 Dec; 96(23):1790-3. PubMed ID: 15572761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
    Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
    J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of ras gene mutations in UV-induced malignant melanomas correlates with a dermal origin of melanocytes in Monodelphis domestica.
    Chan J; Robinson ES; Yeh IT; McCarrey JR
    Cancer Lett; 2002 Oct; 184(1):73-80. PubMed ID: 12104050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
    Rutter JL; Goldstein AM; Dávila MR; Tucker MA; Struewing JP
    Oncogene; 2003 Jul; 22(28):4444-8. PubMed ID: 12853981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent patterns of dual RB and p53 pathway inactivation in melanoma.
    Yang G; Rajadurai A; Tsao H
    J Invest Dermatol; 2005 Dec; 125(6):1242-51. PubMed ID: 16354195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M; Pollock PM; Walters MK; Sparrow LE; Down LM; Gabrielli BG; Parsons PG; Hayward NK
    Cancer Res; 1997 Nov; 57(21):4868-75. PubMed ID: 9354451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
    Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The INK4a/ARF locus and melanoma.
    Sharpless E; Chin L
    Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A melanoma-predisposing germline CDKN2A mutation with functional significance for both p16 and p14ARF.
    Hashemi J; Lindström MS; Asker C; Platz A; Hansson J; Wiman KG
    Cancer Lett; 2002 Jun; 180(2):211-21. PubMed ID: 12175554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a transforming ras oncogene in an ultraviolet radiation-induced corneal tumor of Monodelphis domestica.
    Sabourin CL; Freeman AG; Kusewitt DF; Ley RD
    Photochem Photobiol; 1992 Mar; 55(3):417-24. PubMed ID: 1561240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16 UV mutations in human skin epithelial tumors.
    Soufir N; Molès JP; Vilmer C; Moch C; Verola O; Rivet J; Tesniere A; Dubertret L; Basset-Seguin N
    Oncogene; 1999 Sep; 18(39):5477-81. PubMed ID: 10498902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis.
    Herzog CR; Noh S; Lantry LE; Guan KL; You M
    Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B.
    Soto JL; Cabrera CM; Serrano S; López-Nevot MA
    BMC Cancer; 2005 Apr; 5():36. PubMed ID: 15819981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
    Zhang S; Ramsay ES; Mock BA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.